Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase 4 2Phase 1 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1

Conditions

Peripheral Nervous System Diseases 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Insulin Resistance 1Burns 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 37Zoledronic Acid 34Letrozole 34Sodium Chloride 33Carboplatin 33Bupivacaine 31Bevacizumab 31Docetaxel 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Gemcitabine 22Oxaliplatin 21Morphine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Fenofibrate × Clear all
NCT07025005 2025-11-04

VRd MM Fibrate

Tanta University

Phase 4 Recruiting
44 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Peripheral Nervous System Diseases

NCT01574131 2019-11-29

Acute and Long-Term Outcome Investigations of Fenofibrate on Severely Burned Patients

The University of Texas Medical Branch, Galveston

Phase 4 Terminated
3 enrolled

Burns, Insulin Resistance, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡